Recent advances in BMP receptor signaling - PubMed (original) (raw)
Review
. 2009 Oct-Dec;20(5-6):343-55.
doi: 10.1016/j.cytogfr.2009.10.007. Epub 2009 Nov 7.
Affiliations
- PMID: 19897402
- DOI: 10.1016/j.cytogfr.2009.10.007
Review
Recent advances in BMP receptor signaling
Christina Sieber et al. Cytokine Growth Factor Rev. 2009 Oct-Dec.
Abstract
Bone Morphogenetic Proteins (BMPs) play an important role during organ development and during regeneration after tissue damage. BMPs signal via transmembrane serine/threonine kinase receptors. From our current understanding heteromeric complexes of type I and type II receptors are required for signal propagation. Presently, three type I and three type II receptors are known to bind BMPs with different affinities. Ligands and receptors eventually oligomerize via defined modes into signaling complexes. Co-receptors recruit into these complexes to either inhibit or to promote signaling. The Smad pathway, initiated by phosphorylation through the activated type I receptors, results in transcriptional regulation of early target genes. However, on its way to the nucleus, Smads represent signaling platforms for other pathways, which eventually finetune BMP signal transduction. We also describe BMP-induced signaling cascades leading to cytoskeletal rearrangements, non-transcriptional and non-Smad pathways. BMPs induce a plethora of different cellular effects ranging from stem cell maintenance, migration, differentiation, proliferation to apoptosis. The molecular mechanism, by which the same ligand induces these manifold effects, depends on the cellular context. Here we try to give a current picture of the most important players in regulating and directing BMP signaling towards the desired cellular outcome. Examples of BMP action during development, but also physiological and pathophysiological conditions in the adult organism are presented.
Similar articles
- BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.
Miyazono K, Maeda S, Imamura T. Miyazono K, et al. Cytokine Growth Factor Rev. 2005 Jun;16(3):251-63. doi: 10.1016/j.cytogfr.2005.01.009. Cytokine Growth Factor Rev. 2005. PMID: 15871923 Review. - Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T, Otsuka F, Suzuki J, Takeda M, Inagaki K, Kano Y, Otani H, Mimura Y, Ogura T, Makino H. Miyoshi T, et al. Biol Reprod. 2006 Jun;74(6):1073-82. doi: 10.1095/biolreprod.105.047969. Epub 2006 Jan 25. Biol Reprod. 2006. PMID: 16436528 - Bone morphogenetic protein signal transduction in bone.
ten Dijke P. ten Dijke P. Curr Med Res Opin. 2006;22 Suppl 1:S7-11. doi: 10.1185/030079906X80576. Curr Med Res Opin. 2006. PMID: 16882364 Review. - Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes.
Herpin A, Cunningham C. Herpin A, et al. FEBS J. 2007 Jun;274(12):2977-85. doi: 10.1111/j.1742-4658.2007.05840.x. Epub 2007 May 22. FEBS J. 2007. PMID: 17521337 - PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1.
Bengtsson L, Schwappacher R, Roth M, Boergermann JH, Hassel S, Knaus P. Bengtsson L, et al. J Cell Sci. 2009 Apr 15;122(Pt 8):1248-57. doi: 10.1242/jcs.039552. J Cell Sci. 2009. PMID: 19339557
Cited by
- Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.
Chia ZJ, Kumarapperuma H, Zhang R, Little PJ, Kamato D. Chia ZJ, et al. Acta Pharmacol Sin. 2024 Nov 6. doi: 10.1038/s41401-024-01413-6. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39506064 Review. - Repulsive guidance molecules b (RGMb): molecular mechanism, function and role in diseases.
Zhang J, Jiang Y, Zhang Z, Li S, Fan H, Gu J, Mao R, Xu X. Zhang J, et al. Expert Rev Mol Med. 2024 Oct 8;26:e24. doi: 10.1017/erm.2024.24. Expert Rev Mol Med. 2024. PMID: 39375839 Free PMC article. Review. - Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases.
Lee DH, Lee EC, Lee JY, Lee MR, Shim JW, Oh JS. Lee DH, et al. Biomedicines. 2024 Jun 18;12(6):1350. doi: 10.3390/biomedicines12061350. Biomedicines. 2024. PMID: 38927557 Free PMC article. Review. - Phenotypic characterisation of SMAD4 variant carriers.
Caillot C, Saurin JC, Hervieu V, Faoucher M, Reversat J, Decullier E, Poncet G, Bailly S, Giraud S, Dupuis-Girod S. Caillot C, et al. J Med Genet. 2024 Jul 19;61(8):734-740. doi: 10.1136/jmg-2023-109632. J Med Genet. 2024. PMID: 38575304 Free PMC article. - TGFβ signalling: a nexus between inflammation, placental health and preeclampsia throughout pregnancy.
Horvat Mercnik M, Schliefsteiner C, Sanchez-Duffhues G, Wadsack C. Horvat Mercnik M, et al. Hum Reprod Update. 2024 Jul 1;30(4):442-471. doi: 10.1093/humupd/dmae007. Hum Reprod Update. 2024. PMID: 38519450 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources